GNPX Receives Patent Notice
Genprex receives a notice of allowance from the Canadian Intellectual Property Office for a patent claiming the combination of Reqorsa gene therapy with either PD-1 or PD-L1 antibodies to treat cancer
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.